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Abstract
Background: Oncology is a field that profits tremendously from the genomic data generated by high-throughput
technologies, including next-generation sequencing. However, in order to exploit, integrate, visualize and interpret
such high-dimensional data efficiently, non-trivial computational and statistical analysis methods are required that
need to be developed in a problem-directed manner.
Discussion: For this reason, computational cancer biology aims to fill this gap. Unfortunately, computational cancer
biology is not yet fully recognized as a coequal field in oncology, leading to a delay in its maturation and, as an
immediate consequence, an under-exploration of high-throughput data for translational research.
Summary: Here we argue that this imbalance, favoring ’wet lab-based activities’, will be naturally rectified over time,
if the next generation of scientists receives an academic education that provides a fair and competent introduction to
computational biology and its manifold capabilities. Furthermore, we discuss a number of local educational provisions
that can be implemented on university level to help in facilitating the process of harmonization.
Keywords: Cancer, Computational biology, Genomics data, Computational oncology, Computational genomics,
Statistical genomics, Systems medicine
Background
The origin of molecular oncology is generally traced back
to 1975 when Varmus and Bishop discovered that, what is
now called proto-oncogenes, can initiate cancer in normal
cells [1,2]. Deservedly, their finding was awarded with the
Nobel price in Physiology or Medicine in 1989. This mile-
stone of cancer research (Nature milestones 15) triggered
a myriad of studies leading to an enormous accumulation
of knowledge about molecular and cellular mechanisms
of many different types of cancer. Here, it is important
to note that all of these investigations were based on
technologies and wet lab techniques known prior to the
sequencing of the human genome [3,4].
Interestingly, aside from the main result of the the
Human Genome Project, which was to provide the first
draft of the human DNA, it helped powerful high-
throughput technologies to emerge [5]. These technolo-
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gies changed the face of biology and medicine rapidly in
a profound way. A consequence of these technological
innovations is that, nowadays, we are capable of gen-
erating high-dimensional transcriptomics, proteomics,
metabolomics and imaging data that are containing mea-
surements of thousands and even millions of molecu-
lar variables [6-10]. For this reason, in the post-Human
Genome Project era, we are blessed with the ability to
generate genome-scale data from many molecular and
cellular components allowing us to gain insights into
the pathogenesis of cancer and causal molecular mech-
anisms, at least in principle. Some examples for success
stories can be found in the following studies [11-16] that
demonstrate impressively the power and benefit of com-
putational approaches by providing automatic, consistent
and robust methods to extract information from high-
dimensional data. Despite the fact that some of these
papers have been already published over 10 years ago,
they are still widely cited and influence contemporary
work. We would like to point out that some of the papers
listed above are not specific to cancer research but have a
much wider impact, e.g., [11,15]. Unfortunately, the prac-
tical transition from ‘data’ to ‘information’ and ‘knowledge’
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turned out to be in general a major hurdle and we are
currently still struggling to find the ‘right’ approaches and
methods for this problem.
An important question in this context is if computa-
tional cancer biology is a coequal field in oncology, similar
to other sub-areas specialized in particular cancer types,
e.g., breast cancer, lung cancer or lymphoma, or if it is
merely an ‘auxiliary’ field. Here, we use the term com-
putational cancer biology or computational oncology to
aggregate quantitative fields with oncology to establish
computer-driven approaches, but we are well aware that
other terms are sometimes used as well. Although, many
may be willing to attest computational cancer biology a
similar status as other fields, this liberalism comes swiftly
to an end if it comes to concrete actions. For example, in
terms of funding and the number of employed scientists,
computational cancer biology is currently certainly not at
eye level with other fields in oncology. Examples for this
can be found, e.g., in the MRC strategic plan 2009-2014
that mentions in a 44 page document the term ‘compu-
tational’ just once and ‘bioinformatics’ only twice. Similar
results can be found for the NCI (The National Can-
cer Program: Managing the Nation’s Research Portfolio -
2013) of the NIH (‘computational’ × 1, ‘bioinformatics’ ×
5) in a 88 page document. Also the number of awarded
Training Fellowships by the MRC for Bioinformatics, Bio-
statistics and Methodology was together only 12 from to
a total of 92 awarded Fellowships (13%) in all fields in
2011/12 (Annual Report and Accounts 2011/12) requir-
ing only 7% of the total Fellowship budget. In contrast, 18
(19%) non-clinical Fellowships were awarded consuming
45% of the total budget.
This imbalance is also reflected in the number of
research groups. For instance, the Cancer Research UK
Cambridge Institute, a leading UK institution, employes
20 research groups of which only 2 focus on computa-
tional biology. Similarly, at the Center for Cancer Research
and Cell Biology at the Queen’s University Belfast (UK) we
have 38 research groups in total, but only 3 computational
labs. This is also observable in institutions of other coun-
tries. For instance, the German Cancer Research Center
in Heidelberg has only 9 of its over 90 research groups
with such a focus and the Dana-Farber Cancer Institute in
Boston (USA) employes 16 faculty member in its Depart-
ment of Biostatistics and Computational Biology, whereas
the Department of Cancer Biology and Department of
Medical Oncology have over 200 faculty members.
A similar imbalance can be found in the scientific litera-
ture. For instance, in journals like Nature and Science one
finds rarely articles that focus on computational cancer
biology without analyzing original data at the same time,
even though profound insights are possible from rigor-
ously reanalyzing existing data, as one can see in [17-19].
Specifically, within the last year Nature/Science published
190/96 contributions about cancer research of which only
5/1 had a strong computational biology component.
Discussion
Computational cancer biology as coequal field in oncology
One could wonder why one would like to establish com-
putational cancer biology as a coequal field in oncology at
all? The answer to this question is also the cause of the
problemwe are facing in the post-HumanGenome Project
era: Data!
Specifically, the possibilities opened nowadays by a
number of different high-throughput technologies [20],
including next-generation sequencing, to generate ‘big’
genomics data is, without a doubt, an enormous oppor-
tunity for medicine and pharmacology in general to elu-
cidate systematically the molecular origin of pathologies,
nosology and drug mechanisms [21,22]. On the other
hand, due to the novelty of these technologies, but also
the general availability of high-dimensional data with a
complex correlation structure, methodological develop-
ments are limping far behind our data generation abilities.
These problems can only be overcome by the development
of dedicated analysis approaches because the amounts of
data are even expected to further grow [23].
One problem in this context is that oncology as a field
does, traditionally, not bring up quantitative scientists, but
is mainly concerned with wet lab work and clinical trials.
Although, also these subjects require quantitative anal-
ysis methods, these are certainly not comparable to the
demands triggered by next-generation sequencing (NGS)
data, not to mention the integration of different data
types. For this reason, oncology needs to be comple-
mented with expertise that comes from outside in order
to deal appropriately with these novel data types. Here,
by outside we refer to fields like statistics, computer sci-
ence, physics or signal processing that deal quantitatively
with different aspects of data and that developed a long-
standing history of expertise and success [24,25]. This
expertise is captured in the field computational cancer
biology.
A naturally induced shifting
Potentially, there are many ways how one could coun-
teract this imbalance. However, a rather natural way is
by means of education. Specifically, at the Center for
Cancer Research andCell Biology (CCRCB) at theQueen’s
University Belfast, we are organizing since a couple of
years a summer research program for students. This pro-
gram is open to BSc students and senior high school
(secondary school) students and runs usually between six
and eight weeks throughout the summer months. Dur-
ing this time, the students are distributed to the separate
research groups, including computational biology, at the
Center according to their interests and aspirations.
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A reflection of the value the students attribute to
computational cancer biology can be seen from a recent
poster competition organized by the CCRCB and Cancer
Research UK (CRUK). The task the students were given
was to prepare a poster conveying the following
information:
Imagine you are the Marketing Manager for the Centre
for Cancer Research and Cell Biology (CCRCB) at
Queen’s University Belfast. Your role is to promote the
work of the CCRCB and Belfast Cancer Research UK
Centre throughout Northern Ireland.
As a result from this competition the winner Aaron
Carlisle, a student from Dromore High School (UK),
prepared the successful poster, shown in Figure 1A,
thematizing the need for computational approaches in
cancer research. Among all the topics that could have
been selected, e.g., breast cancer, lung cancer or
leukaemia, Aaron chose to promote the CCRCB based on
research conducted in computational cancer research,
because he realized that, no matter what specific type of
cancer we are dealing with, it requires always a
computational approach. As such:
Computational cancer biology is the common
denominator of modern oncology.
The outcome of this poster competition is very encour-
aging, because it reflects an intuitive appreciation stu-
dents have for computational research in oncology. Here
by intuitive we mean that it is not necessary to under-
stand computational approaches in the very detail in order
to realize their importance and necessity. Biologically, this
may be seen as adaptability of the student population
to environmental pressure in order to improve their fit-
ness. Certainly, the analogy to a self-organizing system has
its limitations, however, it may well be that there are no
strong political interventions necessary that dictate, e.g.,
quota for grants, scientific personnel or publications in
flagship journals like Nature and Science, prescribing the
inclusion of computational cancer research.
So, what is needed to enhance computational cancer
biology?
We think that, in general, there is no doubt about
the importance of computational approaches for cancer
research and for this reason it will only be a matter of
time when computational cancer biology steps out of
the shadow of its big brothers and into the light of a
broad recognition. However, the establishment of certain
boundary conditions will help to enhance this develop-
ment. Because it is outside of our area of influence to
directly change strategic programs of funding bodies, we
discuss here only local solutions that can be implemented
on the School-, Institute- and Department-level.
Education is a key-element in shaping the future of any
field. For this reason we consider the exposure of students
to ‘computational biology’ on all relevant education levels
as a necessary condition to establish a sustainable pro-
gram in computational cancer biology. Specific elements
are:
• Summer internships (summer research program or
summer school for BSc, MSc and PhD students)
• Undergraduate training (BSc course)
• Postgraduate training (MSc course or PhD program)
A B
statistical mathematical
proficiency & knowlege
b
i
o
-
computational biology
Figure 1 The winning poster contribution by Aaron Carlisle for a competition organized by the CCRCB & CRUK (A) and the constituting
parts of computational biology (B).
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• Postdoctoral training (seminars)
• Mentoring of colleagues (seminars, conferences,
workshops)
There are various ways of engagement on these levels,
e.g., via a formal establishment of BSc or MSc courses
or, less formal, by providing individual modules, lecture
series or lectures as a complement to existing programs. It
will depend on the local needs of an institution and on the
amount of commitment one is willing to make. However,
even more important than the quantity of exposure of stu-
dents to this subject, is the quality with which it is taught.
As an example, we just want to briefly remind the reader
to the meaning of a p-value and its relation to the sam-
pling distribution of a null hypothesis. Despite the classic
nature of this topic, going back to Fisher and Neyman, it
causes unease in generations of students, because of two
reasons. First, the topic itself is not trivial at all. Second,
hypothesis testing finds such a wide-spread application, in
essentially every scientific field that generates data, that
the number of qualified scientists who can confidently
teach such subjects is outnumbered by an order of magni-
tude by application focused researches. For computational
approaches this means that before one can sit in front of a
computer to use it for a problem one needs to understand
what one wants to do, which does not require a computer.
This is intimately connected to the usage of software pack-
ages that are capable of solving particular data analysis
problems.
On each of the above mentioned education levels, it
is necessary to teach the students four key skills and
knowledge, and their mutual interplay:
• Computational proficiency
• Statistical proficiency
• Mathematical proficiency
• Biomedical knowledge
It is part of the problem that ‘computational biology’ is
not one-dimensional, but interdisciplinary composed of
different skill sets that are traditionally rooted in differ-
ent subjects (computer science, statistics, physics, signal
processing, applied mathematics, biology and medicine).
However, this interdisciplinary character of computa-
tional biology is a major factor of its strength! Briefly,
computational proficiency ensures independency of avail-
able software and enables the implementation of any
desired algorithm for analysis or visualization. Statistical
and mathematical proficiency allow to design or adapt
methods in a problem-directed manner so they inter-
rogate data in a way to extract important and sensi-
ble biological information. Finally, biological knowledge
is the glue that connects the other parts together; see
Figure 1B for an overview. Hence, education is a nat-
ural key that can unlock many doors and only if we
open all (four) of them, computational cancer biology
emerges.
Practical implementations
The above outline gives only the scaffold of training pro-
grams and we would like to emphasize a number of key
features that appear for us imperative in order to improve
upon many existing programs. First of all, there is a cru-
cial difference between proficiency and knowledge. For
knowledge the emphasize is more on facts and informa-
tion about a problem, whereas proficiency is centered
around skill sets and their application. For instance, com-
putational proficiency cannot be acquired by memorizing
only the syntax of commands of a programming language.
Instead, a programming language needs to be practiced
hands-on in the context of sensible problems. Further-
more, a programming language needs to be taught that
can be actually applied for analyzing real biological data
and not just for showing toy examples. We think that the
statistical programming language R [26] is a good choice
because, currently, it can be considered as the gold stan-
dard in computational biology and biostatistics and is
widely used.
Second, for acquiring statistical andmathematical profi-
ciency it is necessary to connect statistical and mathemat-
ical problems with their computational implementation.
For instance, the teaching of non-parametric hypothe-
sis tests will lead to a deeper understanding of statistical
inference in general and specifically the interplay between
a test statistic and a sampling distribution. Such a level
of understanding cannot be achieved by using ‘point and
click’ software packages because they are hiding all practi-
cal detail levels resulting in an abstract black-box function.
As such, the practical implementation in a programming
language of a statistical model can be seen as de-black-
boxing of the model.
Third, all statistical models are based on a basic under-
standing of analysis, linear algebra and probability theory.
Hence, without proficiency in these mathematical fields
no statistical proficiency can be achieved. This implies
that shortcuts in teaching statistical models by avoiding a
deeper discussion about the former fields will corrupt a
statistical understanding and its proficiency.
Fourth, in order to implement the above measures one
needs to schedule sufficient amount of time in the edu-
cational and training curriculum. That means, based on
the background of students one needs to assess the realis-
tic need for their training to bring them up to the desired
proficiency and knowledge level in computational biol-
ogy. Frequently, the scheduled time framework is over
optimistically chosen resulting in frustrated students and
instructors alike. Computational biology is a difficult sub-
ject and if the training of students does not lead to the
desired outcome the objectives of the training are not met
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and the capabilities of conducting state-of-the art data
analyses is severely impaired.
Accepting limitations
There is one additional point we consider worth empha-
sizing individually. For this reason, let’s consider the fol-
lowing situation: You are hungry but you cannot cook.
What do you do? There are three common options. First,
you go out to a restaurant. Second, you learn how to cook.
Third, you buy a microwave ready meal. It is immediately
clear to everyone that by pursuing the third option you
cannot open a restaurant. Also, the quality of your learned
cooking skills may not be far above a ready meal if you do
not put in the necessary effort.
In the context of computational biology, this example
translates as follows: In the first case, there is a facility
that solves the data analysis problem for you. In the sec-
ond case, you receive training, as discussed in the previous
sections. The third case corresponds to the acquiring of
propriety software that provides you with ready solutions
for standard problems.
For biomedical research including oncology that involve
patients, it seem imperative that only ‘chefs’ should ana-
lyze data and the transition from someone who can-
not cook to a chef takes many years. That means, the
acquired expertise of trainees and students needs to be
fairly assessed and limitations need to be acknowledged in
order to avoid later severe problems, e.g., with respect to
the reproducibility of the results.
Responsibility of funding agencies
We do not want to finish this article without remark-
ing that also research councils, e.g., the Medical Research
Council (MRC, UK), the National Institutes of Health
(NIH, USA) or the European Research Council (ERC,
Europe), bear a responsibility to actively influence the
evolution of computational biology that should com-
plement the above educational initiative. For instance,
the computational biology expertise on grants that pro-
pose a significant generation of data should be an
enforced requirement to ensure a sound experimental
design and analysis of the data. Furthermore, the funding
of PhD studentships and Postdoctoral Research Asso-
ciates could be stirred toward the computational data
analysis rather than data generation because the avail-
ability of large public data repositories allows to work
on biomedical problems without the need to generate
data [27].
It is clear that immediate answers to many urging
questions cannot be given instantly. For this reason it is
commendable that the FT7 program supports the Euro-
pean Network CASYM - COORDINATING ACTION SYS-
TEMS MEDICINE (https://www.casym.eu/), as an initiative
to develop strategies for a realization of systems medicine
rather than to provide right away an implementation of
commonly agreed measures.
Summary
In this paper, we advocated the opinion that an efficient
and natural means for establishing computational biol-
ogy in oncology is provided via the implementation of
broad educational programs. This could lead within one
education-cycle, from BSc via PhD to PDRA - namely
within 8-10 years, to an assertion of the field, without
the need to reformulate other parts of oncology. Here,
it is important to emphasize that education, the key of
this process, should take place on all possible levels, from
BSc students to faculty members, in order to harmonize
existing differences between computational biology and
other parts of oncology naturally, and the more gaps are
between these different levels, the more unstable is the
outcome of the educational process.
Finally, we would like to note that the problem discussed
in this paper has already found appreciation and CASyM
and the Wellcome Trust PhD program in Mathematical
Genomics and Medicine are good examples. However, we
are far away from a general and broad recognition of com-
putational cancer biology as a coequal field in oncology.
We hope that our contribution, which is meant to ini-
tiate a wider discussion of this important issue across all
relevant communities involved in cancer research rather
than as a remedy, will help to establish efficient measures
to make computational cancer biology a powerful force in
fighting cancer.
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